Results 191 to 200 of about 11,077 (219)
Some of the next articles are maybe not open access.
Scores for all seasons: SDAI and CDAI.
Clinical and experimental rheumatology, 2014Disease activity assessment is one of the most pivotal aspects in the care of RA patients. Composite measures of disease activity are superior to individual measures, since they capture the multiple facets of the disease. Since swollen joint counts correlate with joint damage progression and tender joint counts with physical function, composite scores ...
J S, Smolen, D, Aletaha
openaire +1 more source
Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level
Modern Rheumatology, 2009Tocilizumab, a biological agent developed in Japan, is a human anti-interleukin-6 (anti-IL-6) receptor antibody. Rheumatoid arthritis improves with its use. A remission rate of 59% is attainable, as measured by disease activity score 28 (DAS28) in the SAMURAI study.
Keiko, Funahashi +5 more
openaire +2 more sources
Information technology concerning SDAI and CDAI.
Clinical and experimental rheumatology, 2017Disease activity assessment of rheumatoid arthritis has never been trivial. Composite indices like the Disease Activity Score using 28 joint counts 28 (DAS28) and the Clinical Disease Activity Index (CDAI) and the Simplified Disease Activity Index (SDAI) attempted to integrate several core set variables into one readout, which eventually laid the ...
Daniel, Aletaha +2 more
openaire +1 more source
Rheumatology International, 2011
To investigate the clinical results of 1 year tocilizumab (TCZ) treatment of rheumatoid arthritis patients in clinical practice by using the clinical disease activity index (CDAI). Thirty-one patients with inadequate response to DMARDs, including methotrexate (MTX), or TNF inhibitors received TCZ (8 mg every 4 weeks).
Atsushi, Kaneko +4 more
openaire +2 more sources
To investigate the clinical results of 1 year tocilizumab (TCZ) treatment of rheumatoid arthritis patients in clinical practice by using the clinical disease activity index (CDAI). Thirty-one patients with inadequate response to DMARDs, including methotrexate (MTX), or TNF inhibitors received TCZ (8 mg every 4 weeks).
Atsushi, Kaneko +4 more
openaire +2 more sources
AB0233 ATTAINING CDAI REMISSION IS THE FIRST GATEWAY TO ATTAIN BOOLEAN REMISSION
Annals of the Rheumatic Diseases, 2020Background: Boolean remission is most stringent but most comparable remission status for the patient with rheumatoid arthritis (RA). Clinical remission evaluated with clinical disease activity index (CDAI) is also one of the most popular index for evaluation of RA treatment. These two criteria often overlap, but some are split.
openaire +1 more source
THU0344 DAS-28, SDAI and CDAI in the patients with rheumatoid arthritis and concomitant fibromyalgia
Annals of the Rheumatic Diseases, 2012Background Composite indices DAS-28 (Disease Activity Score, assessing 28 joints), SDAI (Simplified Disease Activity Index), CDAI (Clinical Disease Activity Index) are widely used instruments for the assessment of disease activity in the patients (pts) with rheumatoid arthritis (RA), but they may not be sufficient to evaluate activity in cases of RA ...
J. Toms, P. Bradna, T. Soukup, Z. Hrncir
openaire +1 more source
Scandinavian Journal of Rheumatology, 2008
To determine whether the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) are equally applicable for the total population with rheumatoid arthritis (RA).Five hundred and fifty-seven outpatients with RA [432 females, 125 males; median age 64 years (range 18-85); median disease duration 48 months (range 2-548)] were
B, Rintelen +5 more
openaire +2 more sources
To determine whether the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) are equally applicable for the total population with rheumatoid arthritis (RA).Five hundred and fifty-seven outpatients with RA [432 females, 125 males; median age 64 years (range 18-85); median disease duration 48 months (range 2-548)] were
B, Rintelen +5 more
openaire +2 more sources
Commentary: irritable bowel syndrome and the
contrast, more objective measures, such as C-reactive protein (CRP) and haematocrit score, were, as one would predict, higher in Crohn’s patients. It is important to note that one half of all Crohn’s patients in this study appeared to be ‘active’ so one must be cautious in interpreting the application of their findings to Crohn’s patients in true ...
C, Lahiff, A S, Cheifetz
openaire +2 more sources
2018
It is believed that potentially the National Innovation System (NIS) model is a more comprehensive framework for the diffusion of innovation when compared to the integrated approach around cash crops, Training and Visits, and even to the more recently used approaches such as Farming Systems and Multi-Actor Platform.
Eveline M. F. W. Compaoré Sawadogo +1 more
openaire +1 more source
It is believed that potentially the National Innovation System (NIS) model is a more comprehensive framework for the diffusion of innovation when compared to the integrated approach around cash crops, Training and Visits, and even to the more recently used approaches such as Farming Systems and Multi-Actor Platform.
Eveline M. F. W. Compaoré Sawadogo +1 more
openaire +1 more source
Corrélation entre PASS et CDAI dans la polyarthrite rhumatoïde
Revue du Rhumatisme, 2021H. Ben Ayed +9 more
openaire +1 more source